August 11, 2023 10:42 AM EDT
News Briefing

Ake­bia no­ti­fies SEC it will be late fil­ing Q2 earn­ings; Sur­rozen cuts two ear­ly pro­grams

Paul Schloesser

Associate Editor

Tyler Patchen

News Reporter

Ake­bia Ther­a­peu­tics an­nounced Fri­day that it will be late fil­ing its sec­ond-quar­ter earn­ings re­port due to “cer­tain ac­count­ing er­rors” around its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times